Key facts
- This page summarizes Eric Curtis's Form 4 filing for WINDTREE THERAPEUTICS INC /DE/ (WINT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Aug 2023, 18:00.
Eric Curtis - 23 Aug 2023 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)
- Reporting relationship
- SVP & COO
- Issuer ticker
- WINT
- Reported as of
- 23 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2023, 18:00:05 UTC
- Prior SEC filing
- 02 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jamie McAndrew, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Curtis filed Form 4 for WINDTREE THERAPEUTICS INC /DE/ (WINT) on 25 Aug 2023.
Change
- Previous filing in this sequence was filed on 02 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WINT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +14,667
- Change %
- +1171%
- Price
- $0.000000
- Shares after
- 15,920
- Date
- 23 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WINT
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +22,000
- Change %
- Price
- $0.000000
- Shares after
- 22,000
- Date
- 23 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,000
- Exercise price
- $1.21
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
Footnote F2
This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.